Page 48 - Ovarian Cancer Surgery - Quality Indicators

231. Grossi, M., et al. Ovarian cancer: patterns
of care in Victoria during 1993-1995. Med
J Aust 177, 11-16 2002.
232. Cress, R.D., O'Malley, C.D., Leiserowitz,
G.S. & Campleman, S.L. Patterns of
chemotherapy use for women with ovarian
cancer: a population-based study. J Clin
Oncol 21, 1530-1535 2003.
233. Engelen, M.J., et al. Surgery by consultant
gynecologic oncologists improves survival
in patients with ovarian carcinoma. Cancer
106, 589-598 2006.
234. Earle, C.C., et al. Effect of surgeon
specialty on processes of care and
outcomes for ovarian cancer patients. J
Natl Cancer Inst 98, 172-180 2006.
235. Goff, B.A., et al. Ovarian cancer: patterns
of surgical care across the United States.
Gynecol Oncol 103, 383-390 2006.
236. Kumpulainen, S., et al. Surgical treatment
of ovarian cancer in different hospital
categories--a prospective nation-wide
study in Finland. Eur J Cancer 42, 388-
395 2006.
237. Paulsen, T., Kjaerheim, K., Kaern, J.,
Tretli, S. & Trope, C. Improved short-term
survival for advanced ovarian, tubal, and
peritoneal cancer patients operated at
teaching hospitals. Int J Gynecol Cancer
16 Suppl 1, 11-17 2006.
238. Nguyen, H.N., et al. National survey of
ovarian carcinoma. Part V. The impact of
physician's specialty on patients' survival.
Cancer 72, 3663-3670 1993.
239. Skirnisdottir, I. & Sorbe, B. Prognostic
factors for surgical outcome and survival
in 447 women treated for advanced
FIGO -stages III-IV) epithelial ovarian
carcinoma. Int J Oncol 30, 727-734
2007.
240. Chan, J.K., et al. Influence of the
gynecologic oncologist on the survival of
ovarian cancer patients. Obstet Gynecol
109, 1342-1350 2007.
 OVARIAN CANCER SURGERY - QUALITY INDICATORS 
48
241. Eisenkop, S.M., Spirtos, N.M., Montag,
T.W., Nalick, R.H. & Wang, H.J. The
impact of subspecialty training on the
management of advanced ovarian cancer.
Gynecol Oncol 47, 203-209 1992.
242. Bailey, J., Murdoch, J., Anderson, R.,
Weeks, J. & Foy, C. Stage III and IV
ovarian cancer in the South West of
England: five-year outcome analysis for
cases treated in 1998. Int J Gynecol
Cancer 16 Suppl 1, 25-29 2006.
243. Downes, M.R., et al. Review of findings in
prophylactic gynaecological specimens in
Lynch syndrome with literature review and
recommendations for grossing.
Histopathology 65, 228-239 2014.
244. Chen, S.S. & Bochner, R. Assessment of
morbidity and mortality in primary
cytoreductive surgery for advanced
ovarian carcinoma. Gynecol Oncol 20,
190-195 1985.
245. Grant, P.T., Beischer, N.A. & Planner,
R.S. The treatment of gynaecological
malignancy in a general public hospital.
Med J Aust 157, 378-380 1992.
246. Mayer, A.R., et al. Ovarian cancer staging:
does it require a gynecologic oncologist?
Gynecol Oncol 47, 223-227 1992.
247. Puls, L.E., Carrasco, R., Morrow, M.S. &
Blackhurst, D. Stage I ovarian carcinoma:
specialty-related differences in survival
and management. South Med J 90, 1097-
1100 1997.
248. Giede, K.C., Kieser, K., Dodge, J. &
Rosen, B. Who should operate on patients
with ovarian cancer? An evidence-based
review. Gynecol Oncol 99, 447-461
2005.
249. Robinson, W.R., Ritter, J., Rogers, A.S.,
Tedjarati, S. & Lieberenz, C. Clinical trial
participation is associated with improved
outcome in women with ovarian cancer.
Int J Gynecol Cancer 19, 124-128 2009.
250. Rochon, J. & du Bois, A. Clinical research
in epithelial ovarian cancer and patients'